Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Tagrisso is also approved to treat NSCLC with EGFR mutations in the first line metastatic setting as a monotherapy and in combination with chemotherapy, and as an adjuvant treatment for early-stage disease
List price: $1,000 to $1,350
Some report mild, transient nausea in the first 1 to 2 weeks that resolves spontaneously
5 mg/mL doubles the volume
US$ 28.42
US$ 27.93
US$ 24.38
US$ 28.39
US$ 24.40
US$ 28.94
US$ 22.06
US$ 29.29
US$ 21.69
